Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND
3 reports from 3 outlets in 1 language · first reported · updated · JSON

Reports
- Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 INDPublished by manilatimes.net, GlobeNewswire — public companies ·
- Ernexa Therapeutics Advances ERNA-101 Toward Planned Q4 2026 INDrttnews.com · en ·